This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Stuart L. Nightingale, MD
Food and Drug Administration Rockville, Md

JAMA. 1985;253(5):632.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The recent editorial by Dr Archer¹ is a useful addition to the literature exploring the nature and significance of official Food and Drug Administration (FDA) drug labeling and the role of such information in drug selection and use by physicians. The editorial correctly notes that the FDA cannot approve or disapprove of how a physician uses lawfully marketed drugs. The FDA can and does, however, approve indications for a drug's use and approves what a drug manufacturer may say in labeling, advertising, or publications intended to acquaint physicians with a drug's properties and uses. Although FDA officials^2,3 have over the years sought to clarify the status and role of approved drug labeling, we felt that a wider audience needed to have an authoritative policy statement on this issue. We chose the FDA Drug Bulletin,⁴ as Archer notes, as the most appropriate vehicle since it . . . [Full Text PDF of this Article]

Footnotes
Edited by Drummond Rennie, MD, Senior Contributing Editor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?